Showing results (111-120 of 160) with videos related to
Sort By:
Pageof 16
Journal of Hepatology|January 1, 2017
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosisThomas Karlas, David Petroff, Magali Sasso, et al.Journal of Hepatology|April 12, 2020
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementMohammed Eslam, Philip N Newsome, Shiv K Sarin, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 12, 2021
Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) RegistryZobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, et al.Hepatology (Baltimore, Md.)|March 16, 2023
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetesGrazia Pennisi, Marco Enea, Vincenzo Falco, et al.Aging Cell|May 31, 2026
Liver Aging Index: A Noninvasive Score for Liver Biological Aging and Liver-Related Outcomes in MulticohortsZhiyu Wu, Shanshan Wu, Shuyao Song, et al.Gut|March 2, 2026
Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statementChu-Tian Wu, Giovanni Targher, Christopher D Byrne, et al.JAMA|March 21, 2024
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver DiseaseHuapeng Lin, Hye Won Lee, Terry Cheuk-Fung Yip, et al.Journal of Hepatology|January 25, 2025
Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver diseaseTerry Cheuk-Fung Yip, Hye Won Lee, Huapeng Lin, et al.Hepatology (Baltimore, Md.)|December 26, 2025
Head-to-head comparison between vibration-controlled transient elastography and histology in predicting liver-related events due to metabolic dysfunction-associated steatotic liver diseaseYangyue Zhang, Hye Won Lee, Huapeng Lin, et al.Clinical and Molecular Hepatology|November 11, 2025
Histological severity and hepatic outcomes in patients with MASLD and discrepant FIB-4 and liver stiffness measurementJoseph Rabbat, Boyu Yang, Hye Won Lee, et al.Pageof 16